Month: February 2011

The Third BHD Symposium will be held this year on 11th and 12th May in Maastricht, the Netherlands. Researchers interested in presenting at the Symposium have just over two weeks to submit their abstracts before the deadline on 15th March. The Symposium welcomes scientists and patients from around the world who are interested in BHD … Read more

There are now just 9 days left until Rare Disease Day this year. It is very exciting that families, organizations, businesses and governments in 46 countries will be holding events to mark this day and set strategies for the year ahead.  Rare Disease Day was only newly established in 2008 by EURORDIS, which continues to … Read more

In two separate posts in June and July last year, Duncan discussed a paper by Hong et al. (2010), which demonstrated that a loss of FLCN affected TGF-β signalling. This particular finding has now been expanded upon by experiments which show that FLCN also regulates apoptosis through TGF-β-mediated transcription in mouse embryonic stem (ES) cells … Read more

A large part of BHD research focuses on elucidating the role of folliculin in the cell and understanding the effects of folliculin loss. Another important aspect of BHD research is developing therapeutic treatments for BHD syndrome, and in particular for renal cell carcinoma (RCC). In light of this, a recent paper by Lu et al. … Read more